These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24452408)

  • 1. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.
    Nakagawa K; Tanaka K; Nojiri K; Kumamoto T; Takeda K; Ueda M; Endo I
    Ann Surg Oncol; 2014 May; 21(5):1711-8. PubMed ID: 24452408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Glasgow Prognostic Score and Carcinoembryonic Antigen Predict Poor Prognosis in Elderly Patients with Colorectal Cancer.
    Numata K; Ono Y; Toda S; Kamioka Y; Suematsu H; Sawazaki S; Tsuchida K; Higuchi A; Saeki H; Rino Y; Masuda M; Matsukawa H
    Oncol Res Treat; 2020; 43(4):125-133. PubMed ID: 32040953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
    Uratani R; Toiyama Y; Shimura T; Mori K; Fujikawa H; Hiro J; Ohi M; Inoue Y; Tanaka K; Araki T; Mohri Y; Kusunoki M
    Anticancer Res; 2015 Oct; 35(10):5639-48. PubMed ID: 26408737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Tsuchihashi K; Ito M; Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama A; Denda T; Satake H; Suto T; Sugimoto N; Katsumata K; Ishikawa T; Kashiwada T; Oki E; Komatsu Y; Okuyama H; Sakai D; Ueno H; Tamura T; Yamashita K; Kishimoto J; Shimada Y; Baba E
    Clin Colorectal Cancer; 2018 Dec; 17(4):e687-e697. PubMed ID: 30149986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of the high-sensitivity modified glasgow prognostic score on patients undergoing radical surgery for hepatocellular carcinoma : Authorship.
    Luo B; Zhang Y; Zhu X; Ji T; Wu K; Sun D; Lu Y; Shi L
    Langenbecks Arch Surg; 2024 Jul; 409(1):223. PubMed ID: 39023651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
    Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
    Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer.
    Kobayashi T; Kawakamil M; Hara Y; Shioiri S; Yasuno M; Teruya M; Kaminishi M
    Hepatogastroenterology; 2014; 61(133):1359-62. PubMed ID: 25436311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis.
    Okimoto S; Kobayashi T; Tashiro H; Kuroda S; Ishiyama K; Ide K; Abe T; Hashimoto M; Iwako H; Hamaoka M; Honmyo N; Yamaguchi M; Ohdan H
    Int J Surg; 2017 Jun; 42():209-214. PubMed ID: 28483664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of C-reactive protein and albumin in patients undergoing resection of colorectal liver metastases. A retrospective cohort study.
    Frühling P; Hellberg K; Ejder P; Strömberg C; Urdzik J; Isaksson B
    HPB (Oxford); 2021 Jun; 23(6):970-978. PubMed ID: 33214053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
    Schmidt T; Nienhüser H; Kuna C; Klose J; Strowitzki MJ; Büchler MW; Ulrich A; Schneider M
    Eur J Surg Oncol; 2018 Oct; 44(10):1610-1618. PubMed ID: 30115500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
    Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
    Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
    Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    Peltonen R; Gramkow MH; Dehlendorff C; Osterlund PJ; Johansen JS; Isoniemi H
    PLoS One; 2020; 15(8):e0236569. PubMed ID: 32756596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.